Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 12 studies | 21% ± 5% | |
brain | 12 studies | 32% ± 17% | |
peripheral blood | 11 studies | 27% ± 12% | |
eye | 7 studies | 29% ± 10% | |
pancreas | 4 studies | 29% ± 16% | |
uterus | 4 studies | 31% ± 14% | |
breast | 4 studies | 25% ± 7% | |
intestine | 4 studies | 25% ± 8% | |
liver | 4 studies | 25% ± 10% | |
lymph node | 4 studies | 22% ± 5% | |
adipose | 4 studies | 21% ± 4% | |
kidney | 3 studies | 20% ± 3% | |
bone marrow | 3 studies | 25% ± 8% | |
thymus | 3 studies | 26% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 5453.55 | 459 / 459 | 100% | 30.65 | 1118 / 1118 |
esophagus | 100% | 5251.91 | 1445 / 1445 | 100% | 24.51 | 183 / 183 |
ovary | 100% | 7512.16 | 180 / 180 | 100% | 17.87 | 430 / 430 |
prostate | 100% | 5798.72 | 245 / 245 | 100% | 20.26 | 502 / 502 |
uterus | 100% | 7028.85 | 170 / 170 | 100% | 22.79 | 459 / 459 |
lung | 100% | 5972.61 | 577 / 578 | 100% | 19.65 | 1153 / 1155 |
bladder | 100% | 5392.81 | 21 / 21 | 100% | 18.80 | 502 / 504 |
brain | 99% | 4049.47 | 2625 / 2642 | 100% | 26.43 | 705 / 705 |
thymus | 100% | 6514.33 | 653 / 653 | 99% | 22.58 | 601 / 605 |
stomach | 100% | 4488.77 | 359 / 359 | 99% | 19.93 | 283 / 286 |
pancreas | 99% | 2807.36 | 326 / 328 | 99% | 17.11 | 177 / 178 |
skin | 100% | 6769.28 | 1809 / 1809 | 99% | 21.02 | 465 / 472 |
intestine | 100% | 6269.38 | 966 / 966 | 98% | 18.71 | 517 / 527 |
adrenal gland | 100% | 4545.93 | 258 / 258 | 98% | 14.99 | 225 / 230 |
kidney | 100% | 3652.26 | 89 / 89 | 98% | 15.57 | 880 / 901 |
liver | 100% | 2864.91 | 226 / 226 | 92% | 9.48 | 372 / 406 |
adipose | 100% | 5599.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.31 | 29 / 29 |
muscle | 100% | 4056.16 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6405.21 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.89 | 1 / 1 |
blood vessel | 100% | 4989.47 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2797.52 | 848 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 20.18 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 84% | 10.61 | 67 / 80 |
peripheral blood | 70% | 3001.13 | 650 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0048568 | Biological process | embryonic organ development |
GO_0001701 | Biological process | in utero embryonic development |
GO_0061053 | Biological process | somite development |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0035264 | Biological process | multicellular organism growth |
GO_0006260 | Biological process | DNA replication |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0005730 | Cellular component | nucleolus |
GO_0016607 | Cellular component | nuclear speck |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RBBP6 |
Protein name | RB binding protein 6, ubiquitin ligase E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis) Alternative protein RBBP6 |
Synonyms | PACT RBQ1 My038 P2PR |
Description | FUNCTION: E3 ubiquitin-protein ligase which promotes ubiquitination of YBX1, leading to its degradation by the proteasome . May play a role as a scaffold protein to promote the assembly of the p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated ubiquitination and degradation of p53/TP53; may function as negative regulator of p53/TP53, leading to both apoptosis and cell growth (By similarity). Regulates DNA-replication and the stability of chromosomal common fragile sites (CFSs) in a ZBTB38- and MCM10-dependent manner. Controls ZBTB38 protein stability and abundance via ubiquitination and proteasomal degradation, and ZBTB38 in turn negatively regulates the expression of MCM10 which plays an important role in DNA-replication . .; FUNCTION: (Microbial infection) [Isoform 1]: Restricts ebolavirus replication probably by impairing the vp30-NP interaction, and thus viral transcription. . |
Accessions | Q7Z6E9 H3BUN0 L8E7X2 ENST00000562683.2 ENST00000564314.5 ENST00000646282.1 ENST00000567686.5 ENST00000381039.7 [Q7Z6E9-4] ENST00000452655.6 [Q7Z6E9-3] A0A2R8Y880 H3BSK8 ENST00000348022.6 [Q7Z6E9-2] ENST00000319715.10 [Q7Z6E9-1] ENST00000568015.5 I3L3Y2 A0A087WY32 |